Sulfonylamide Compounds as CDK2 Inhibitors for Treating Cancer
- ACS Med Chem Lett. 2021 Sep 13;12(10):1528-1529. doi: 10.1021/acsmedchemlett.1c00471.
Affiliations
- 1. Smith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia 30309, United States.
PMID: 34676031
DOI: 10.1021/acsmedchemlett.1c00471